Canadian Blood and Tissue Bank Insception Life Blood claims that 80 life threatening diseases (e.g. various cancers, metabolic diseases, immune diseases etc.) can be treated with umbilical cord blood, and that these diseases have been treated with success for over 2 decades, with over 45,000 pediatric transfusions worldwide. The majority of these transfusions however were accomplished due to public cord blood banks. Physicians can tap into worldwide public registries with nearly 1,000,000 (1 million) donors to find a match for a patient and this service is free. In the setting of leukemia or a genetic defect, physicians would want to use cord blood which is not biologically related to the patient to avoid having the problem continue. The American Academy of Pediatrics states, “private storage of cord blood as biological insurance should be discouraged”. There is a caveat to this however, in the case of a child having a genetic defect, it is recommended that the family save the cord blood of the next child, if another child is born. It is believed that private cord blood corporations leverage fear, uncertainty, and timed pressure to cajole families into deciding to privately store cord blood. Insception Life Blood has stored cord blood from 70,000 infants yet only 14 were released for transplant, a value of 1 in 5000